Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell ; 80(3): 423-436.e9, 2020 11 05.
Article in English | MEDLINE | ID: mdl-33022275

ABSTRACT

The ubiquitin system regulates the DNA damage response (DDR) by modifying histone H2A at Lys15 (H2AK15ub) and triggering downstream signaling events. Here, we find that phosphorylation of ubiquitin at Thr12 (pUbT12) controls the DDR by inhibiting the function of 53BP1, a key factor for DNA double-strand break repair by non-homologous end joining (NHEJ). Detectable as a chromatin modification on H2AK15ub, pUbT12 accumulates in nuclear foci and is increased upon DNA damage. Mutating Thr12 prevents the removal of ubiquitin from H2AK15ub by USP51 deubiquitinating enzyme, leading to a pronounced accumulation of ubiquitinated chromatin. Chromatin modified by pUbT12 is inaccessible to 53BP1 but permissive to the homologous recombination (HR) proteins RNF169, RAD51, and the BRCA1/BARD1 complex. Phosphorylation of ubiquitin at Thr12 in the chromatin context is a new histone mark, H2AK15pUbT12, that regulates the DDR by hampering the activity of 53BP1 at damaged chromosomes.


Subject(s)
DNA Damage/physiology , Tumor Suppressor p53-Binding Protein 1/metabolism , Ubiquitin/metabolism , Animals , Cell Line , Cell Line, Tumor , Chromatin/metabolism , DNA/metabolism , DNA Breaks, Double-Stranded , DNA Damage/genetics , DNA End-Joining Repair/genetics , DNA Repair/genetics , DNA-Binding Proteins/metabolism , Histones/metabolism , Homologous Recombination/physiology , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Nuclear Proteins/metabolism , Phosphorylation , Signal Transduction/genetics , Threonine/metabolism , Tumor Suppressor p53-Binding Protein 1/physiology , Ubiquitin/genetics , Ubiquitin-Protein Ligases/metabolism , Ubiquitination
2.
J Cell Biol ; 219(8)2020 08 03.
Article in English | MEDLINE | ID: mdl-32597933

ABSTRACT

DNA replication is highly regulated by the ubiquitin system, which plays key roles upon stress. The ubiquitin-like modifier ISG15 (interferon-stimulated gene 15) is induced by interferons, bacterial and viral infection, and DNA damage, but it is also constitutively expressed in many types of cancer, although its role in tumorigenesis is still largely elusive. Here, we show that ISG15 localizes at the replication forks, in complex with PCNA and the nascent DNA, where it regulates DNA synthesis. Indeed, high levels of ISG15, intrinsic or induced by interferon-ß, accelerate DNA replication fork progression, resulting in extensive DNA damage and chromosomal aberrations. This effect is largely independent of ISG15 conjugation and relies on ISG15 functional interaction with the DNA helicase RECQ1, which promotes restart of stalled replication forks. Additionally, elevated ISG15 levels sensitize cells to cancer chemotherapeutic treatments. We propose that ISG15 up-regulation exposes cells to replication stress, impacting genome stability and response to genotoxic drugs.


Subject(s)
Bone Neoplasms/metabolism , Chromosome Breakage , Cytokines/metabolism , DNA Replication , DNA, Neoplasm/biosynthesis , Osteosarcoma/metabolism , Ubiquitins/metabolism , Antineoplastic Agents/pharmacology , Bone Neoplasms/drug therapy , Bone Neoplasms/genetics , Bone Neoplasms/pathology , Cytokines/genetics , DNA Damage , DNA, Neoplasm/genetics , Dose-Response Relationship, Drug , HEK293 Cells , HeLa Cells , Humans , MCF-7 Cells , Osteosarcoma/drug therapy , Osteosarcoma/genetics , Osteosarcoma/pathology , Proliferating Cell Nuclear Antigen/genetics , Proliferating Cell Nuclear Antigen/metabolism , RecQ Helicases/genetics , RecQ Helicases/metabolism , Time Factors , Ubiquitins/genetics
3.
Sci Rep ; 9(1): 951, 2019 01 30.
Article in English | MEDLINE | ID: mdl-30700749

ABSTRACT

Ewing sarcoma is the second most common pediatric bone and soft tissue tumor presenting with an aggressive behavior and prevalence to metastasize. The diagnostic translocation t(22;11)(q24;12) leads to expression of the chimeric oncoprotein EWS-FLI1 which is uniquely expressed in all tumor cells and maintains their survival. Constant EWS-FLI1 protein turnover is regulated by the ubiquitin proteasome system. Here, we now identified ubiquitin specific protease 19 (USP19) as a regulator of EWS-FLI1 stability using an siRNA based screening approach. Depletion of USP19 resulted in diminished EWS-FLI1 protein levels and, vice versa, upregulation of active USP19 stabilized the fusion protein. Importantly, stabilization appears to be specific for the fusion protein as it could not be observed neither for EWSR1 nor for FLI1 wild type proteins even though USP19 binds to the N-terminal EWS region to regulate deubiquitination of both EWS-FLI1 and EWSR1. Further, stable shUSP19 depletion resulted in decreased cell growth and diminished colony forming capacity in vitro, and significantly delayed tumor growth in vivo. Our findings not only provide novel insights into the importance of the N-terminal EWSR1 domain for regulation of fusion protein stability, but also indicate that inhibition of deubiquitinating enzyme(s) might constitute a novel therapeutic strategy in treatment of Ewing sarcoma.


Subject(s)
Endopeptidases/metabolism , Oncogene Proteins, Fusion/metabolism , Proto-Oncogene Protein c-fli-1/metabolism , RNA-Binding Protein EWS/metabolism , Sarcoma, Ewing/metabolism , Sarcoma, Ewing/pathology , Ubiquitination , Animals , Cell Proliferation , Humans , Mice , Models, Biological , Oncogene Proteins, Fusion/chemistry , Protein Domains , Protein Stability , Proto-Oncogene Protein c-fli-1/chemistry , RNA, Small Interfering/metabolism , RNA-Binding Protein EWS/chemistry
4.
Mol Cell ; 71(6): 897-910.e8, 2018 09 20.
Article in English | MEDLINE | ID: mdl-30122534

ABSTRACT

Chromatin ubiquitination by the ubiquitin ligase RNF168 is critical to regulate the DNA damage response (DDR). DDR deficiencies lead to cancer-prone syndromes, but whether this reflects DNA repair defects is still elusive. We identified key factors of the RNF168 pathway as essential mediators of efficient DNA replication in unperturbed S phase. We found that loss of RNF168 leads to reduced replication fork progression and to reversed fork accumulation, particularly evident at repetitive sequences stalling replication. Slow fork progression depends on MRE11-dependent degradation of reversed forks, implicating RNF168 in reversed fork protection and restart. Consistent with regular nucleosomal organization of reversed forks, the replication function of RNF168 requires H2A ubiquitination. As this novel function is shared with the key DDR players ATM, γH2A.X, RNF8, and 53BP1, we propose that double-stranded ends at reversed forks engage classical DDR factors, suggesting an alternative function of this pathway in preventing genome instability and human disease.


Subject(s)
DNA Damage/physiology , DNA Repair/physiology , Histones/metabolism , Cell Line , DNA Breaks, Double-Stranded , DNA Replication/physiology , DNA-Binding Proteins/metabolism , Humans , S Phase/physiology , Signal Transduction , Tumor Suppressor p53-Binding Protein 1/metabolism , Ubiquitin-Protein Ligases/metabolism , Ubiquitination/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...